Reference priceEUR €10.16Original source price: INR 923.66. Converted estimates are available by currency selection.
| Brand | Sun Pharmaceuticals Industries ltd. |
|---|---|
| Manufacturer | Sun Pharmaceuticals Industries ltd. |
| Prescription required | Yes |
Letroz 2.5mg Tablet
Letrozole (2.5mg)
Description
Letroz 2.5mg is an anti-cancer drug that belongs to the class aromatase inhibitor. It is indicated as a supportive therapy after the main therapy or first-line therapy for postmenopausal women with early and advanced breast cancer whose tumors are hormone receptor-positive.Since high amounts of estrogen are found to trigger breast cancer, this medicine reduces the levels of the female reproductive hormone by blocking the enzyme (aromatase) that is involved in the production of estrogen.Benefits
Uses of Letroz 2.5mg Tablet 1.First and second-line treatment of postmenopausal women with hormone receptor-positive breast cancer. 2.Supportive to standard treatment for postmenopausal women with early breast cancer. 3.Treatment for unknown advanced breast cancer in postmenopausal women. 4.Extended supportive therapy for postmenopausal women with early breast cancer who have already taken other anti-cancer medication.How to Use
Take this medicine in the dose and duration as advised by your doctor.Specification
Take this medicine in the dose and duration as advised by your doctor.Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them *Common side effects of Letroz Dizziness Fatigue Weakness Bone pain Back pain Night sweats Joint pain Nausea Osteoporosis Joint inflammation Weight gain Hot flushes Edema (swelling) Flushing (sense of warmth in the face, ears, neck and trunk) Diaphoresis Bone fracture Hypercholesterolemia (high cholesterol) Cough Shortness of breathDiese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.